TOKYO, Mar 11 (Pulse News Wire) – Kringle Pharma, Inc. (4884) has revised its earnings forecast. FORECAST REVISION SUMMARY: (Unit: ) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) 72 △1,172 △1,172 △1,173 Revised Forecast (B) 332 △1 △1,018 △1,020 Change (B-A) 260 153 153 153 Prior Year Actual 72 △909 △914 △916 KEY CHANGES: - Net profit forecast raised to △1,020 - Operating profit forecast raised to △1 REASON FOR REVISION: ( ) (260) Ⅲ IND 107
Forecast revision — FY2026/9Upward revision
| Metric | Prior | Revised | Change |
|---|---|---|---|
| Revenue | ¥72M | ¥332M | +361.8% |
| Op. profit | ¥-1,172M | ¥-1M | |
| Net profit | ¥-1,173M | ¥-1,020M |
Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.